LONG-TERM EFFICACY, CURATIVE POTENTIAL, AND CARCINOGENICITY OF TOPICAL MECHLORETHAMINE CHEMOTHERAPY IN CUTANEOUS T-CELL LYMPHOMA

被引：182

作者：

VONDERHEID, EC

TAN, ET

KANTOR, AF

SHRAGER, L

MICAILY, B

VANSCOTT, EJ

机构：

[1] TEMPLE UNIV,HLTH SCI CTR,DEPT DERMATOL,PHILADELPHIA,PA 19140

[2] TEMPLE UNIV,HLTH SCI CTR,DEPT FAMILY PRACTICE,PHILADELPHIA,PA 19140

[3] TEMPLE UNIV,HLTH SCI CTR,DEPT COMMUNITY HLTH,PHILADELPHIA,PA 19140

[4] NIH,DIV CANC ETIOL,EPIDEMIOL & BIOSTAT PROGRAM,BETHESDA,MD 20205

[5] HAHNEMANN MED CTR,DEPT RADIAT ONCOL,PHILADELPHIA,PA

来源：

关键词：

D O I：

10.1016/S0190-9622(89)70051-7

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：416 / 428

页数：13

共 66 条

[1] CUTANEOUS MALIGNANCIES AND METASTATIC SQUAMOUS-CELL CARCINOMA FOLLOWING TOPICAL THERAPIES FOR MYCOSIS-FUNGOIDES
ABEL, EA
SENDAGORTA, E
HOPPE, RT
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (06) : 1029 - 1038
[2] BUNN PA, 1979, CANCER TREAT REP, V63, P725
[3] THYMOPOIETIN-LIKE SUBSTANCE IN HUMAN-SKIN
CHU, AC
PATTERSON, JAK
GOLDSTEIN, G
BERGER, CL
TAKEZAKI, S
EDELSON, RL
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 81 (03) : 194 - 197
[4] COHEN SR, 1980, CANCER, V46, P2654, DOI 10.1002/1097-0142(19801215)46:12<2654::AID-CNCR2820461220>3.0.CO
[5] 2-1
[6] COX DR, 1972, J R STAT SOC B, V34, P187
[7] Dixon W. I, 1983, BMDP BIOMEDICAL COMP
[8] LYMPHOMATOID PAPULOSIS AND PRIMARY CUTANEOUS HODGKINS-DISEASE
DOWD, PM
MUNRO, DD
STANSFELD, AG
[J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1981, 74 (01) : 68 - 71
[9] DUVIVIER A, 1978, BRIT J DERMATOL, V99, P61
[10] NITROGEN-MUSTARD (MECHLORETHAMINE) AND UVB PHOTOCARCINOGENESIS - A DOSE-RESPONSE EFFECT
EPSTEIN, JH
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 83 (05) : 320 - 322